Companies › APYX

APYX MEDICAL CORPORATION (APYX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000719135 · EDGAR filings · Updated 2026-07-24

APYX MEDICAL CORPORATION (APYX) has reported institutional ownership of 49.7%, with 67 institutional managers holding positions valued at $76.6M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-24 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-21 — SCHEDULE 13G/A filed
• 2026-07-02 — Insider transaction reported (Form 4)
• 2026-06-26 — Proxy statement (DEF 14A) filed
• 2026-06-17 — Insider transaction reported (Form 4)
• 2026-06-17 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, APYX MEDICAL CORPORATION has 67 institutional holders and institutional ownership of 49.7%.

Insider activity

Insiders reported 2 transactions (0 buys, 0 sells) across 2 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Related companies

DIAMEDICA THERAPEUTICS INC (DMAC) · STEREOTAXIS INC (STXS) · PROMIS NEUROSCIENCES INC (PMN) · PROKIDNEY CORP (PROK) · AN2 Therapeutics Inc (ANTX) · SANUWAVE HEALTH INC (SNWV)